Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Nanomedicine play Midatech raises L32 million in IPO

    Midatech Pharma plc (LSE:MTPH) raised L32 million ($49.8 million) through the sale of 12 million shares at 267p in an IPO on the London Stock Exchange's AIM. The price valued Midatech at L74.2 million ($115.4 million). …

    Published on 12/8/2014
  • FINANCIAL NEWS: Trevena raises $45M in follow-on

    Trevena Inc. (NASDAQ:TRVN) raised $45 million through the sale of 11.3 million shares at $4 in a follow-on underwritten by Barclays; Cowen; Jefferies; JMP; and Needham. Trevena proposed to raise $40 million on Nov. 20. …

    Published on 12/5/2014
  • FINANCIAL NEWS: von Emster leaving venBio for Abingworth

    Longtime biotech portfolio manager and VC Kurt von Emster has departed venBio, which he co-founded in 2009, and will join Abingworth as a partner in January.Abingworth said von Emster will work out of the London firm's …

    Published on 12/5/2014
  • FINANCIAL NEWS: BTG raises L150M, acquires PneumRx

    BTG plc (LSE:BTG) raised L150 million ($234.8 million) through the sale of 18.9 million shares at 795p in a placing underwritten by Deutsche Bank and JPMorgan. Invesco Asset Management purchased 3.3 million shares worth…

    Published on 12/4/2014
  • FINANCIAL NEWS: Evgen to list on AIM

    Evgen Pharma plc (Liverpool, U.K.) plans to raise up to L20 million ($31.3 million) in an IPO on the London Stock Exchange's AIM. The company expects shares to begin trading in mid-December. Westhouse Securities is the …

    Published on 12/4/2014
  • FINANCIAL NEWS: HBM joins Allena syndicate in $25M series B

    Allena Pharmaceuticals Inc. (Newton, Mass.) raised $25 million in a series B financing led by HBM Partners. Existing investors Frazier Healthcare; Third Rock Ventures; Bessemer Venture Partners; and new investor …

    Published on 12/4/2014
  • FINANCIAL NEWS: New Leaf closes $200M growth equity fund

    New Leaf Venture Partners closed a $200 million growth equity fund that will focus solely on investments in later-stage public biopharma companies. The firm's Philippe Chambon told BioCentury that New Leaf Growth Fund I…

    Published on 12/4/2014
  • FINANCIAL NEWS: Histogenics raises $65M in IPO

    Histogenics Corp. (NASDAQ:HSGX) rose $0.75 to $11.75 in its first day of trading after raising $65 million in an IPO on NASDAQ through the sale of 5.9 million shares at $11. The price valued Histogenics at $140.3 …

    Published on 12/3/2014
  • FINANCIAL NEWS: Naurex raises $80M in series C

    Neurology play Naurex Inc. (Evanston, Ill.) raised $80 million in an untranched series C round with new investors Cowen; EcoR1 Capital; Goudy Park Capital; Portola Capital; and Sabby Capital. Existing investors Adams …

    Published on 12/3/2014
  • FINANCIAL NEWS: Xeltis raises EUR 27M in series B

    Regenerative medicine play Xeltis AG (Zurich, Switzerland) raised EUR 27 million ($33.6 million) in a series B round led by new investors Life Sciences Partners and Kurma Partners. New investor VI Partners and …

    Published on 12/3/2014
  • FINANCIAL NEWS: Apellis raises $33M in series C

    Autoimmune disease play Apellis Pharmaceuticals Inc. (Crestwood, Ky.) closed a $33 million series C round led by existing investor Morningside Ventures and new investor AJU IB Investment Co. Ltd. Epidarex Capital, …

    Published on 12/2/2014
  • FINANCIAL NEWS: Canbridge raises $10M in series A

    Canbridge Life Sciences Ltd. (Beijing, China) raised $10 million in a series A round from Qiming Venture Partners and TF Capital. Canbridge in-licenses compounds from small biotechs in the U.S. and Europe to develop in …

    Published on 12/2/2014
  • FINANCIAL NEWS: Flexion proposes follow-on after FDA hold lifted

    Flexion Therapeutics Inc. (NASDAQ:FLXN) proposed to raise up to $69 million in a follow-on underwritten by BMO and RBC. The news came after Flexion announced postmarket Monday that FDA lifted a clinical hold on FX006 to…

    Published on 12/2/2014
  • FINANCIAL NEWS: Gene therapy play Audentes raises $42.5M

    Audentes Therapeutics Inc. (San Francisco, Calif.) raised $42.5 million in a series B round led by Deerfield Management. New investors Sofinnova Ventures and Venrock and existing investors OrbiMed, 5AM Ventures and …

    Published on 12/2/2014
  • FINANCIAL NEWS: Microbiome company Seres raises $48M

    Seres Health Inc. (Cambridge, Mass.) raised $48 million in a series C round with undisclosed public investors. Neither Seres nor founding investor Flagship Ventures would tell BioCentury who any of the investors in the …

    Published on 12/2/2014
  • FINANCIAL NEWS: PMV raises $30M series A

    PMV Pharmaceuticals Inc. (Redwood City, Calif.) raised $30 million in a series A round led by OrbiMed. Osage University Partners and founding investor InterWest Partners also participated. Peter Thompson, a private …

    Published on 12/2/2014
  • FINANCIAL NEWS: Ascendis raises $60M series D

    Prodrug technology developer Ascendis Pharma A/S (Copenhagen, Denmark) raised $60 million in a series D round led by Sofinnova Ventures; OrbiMed; and Vivo Capital. Janus Capital; Venrock; RA Capital; Rock Springs …

    Published on 12/1/2014
  • FINANCIAL NEWS: MDx play Curetis adds to B round

    Molecular diagnostics company Curetis AG (Holzgerlingen, Germany) raised EUR 14.5 million ($18 million) in an extension of its series B round. New investors Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN) and LSP Health Economics …

    Published on 12/1/2014
  • FINANCIAL NEWS: Genomics Ltd. raises L10.3 million

    Sequencing analytics play and University of Oxford spin-out Genomics Ltd. (Oxford, U.K.) raised L10.3 million ($16.1 million) in its "first significant" round of funding, according to CEO John Colenutt. New investors …

    Published on 11/26/2014
  • FINANCIAL NEWS: Kite proposes $138M follow-on

    Kite Pharma Inc. (NASDAQ:KITE) said it plans to raise up to $138 million in a follow-on underwritten by Jefferies; Credit Suisse; Cowen; and Stifel. Kite raised $146.6 million through the sale of 8.6 million shares at $…

    Published on 11/26/2014
  • FINANCIAL NEWS: S1 Biopharma amends IPO

    S1 Biopharma Inc. (New York, N.Y.) amended its IPO on NASDAQ and plans to sell 1.75 million units at $12-$14. At $13, the company would raise $22.8 million and be valued at $105.7 million. Each unit comprises one share …

    Published on 11/26/2014
  • FINANCIAL NEWS: Eleven raises $20M in private placement

    Eleven Biotherapeutics Inc. (NASDAQ:EBIO) raised $20 million through the sale of 1.7 million shares at $11.47 in a private placement with undisclosed investors. The company also issued three-year warrants to purchase …

    Published on 11/25/2014
  • FINANCIAL NEWS: Medgenics raises $21M in follow-on

    Medgenics Inc. (NYSE-M:MDGN) raised $21 million through the sale of 5.1 million shares at $4.10 in a follow-on underwritten by Piper Jaffray and JMP Securities.Medgenics' lead compound, TARGTEPO (MDGN-201), is in Phase …

    Published on 11/25/2014
  • FINANCIAL NEWS: Promethera raises EUR 20.3M in series C

    Liver disease company Promethera Biosciences S.A. (Mont-Saint-Guibert, Belgium) raised EUR 20.3 million ($25.2 million) in a series C round led by existing investor Vesalius BioCapital. New investors included Germany's …

    Published on 11/25/2014
  • FINANCIAL NEWS: Ampio's Vyrix withdraws IPO

    The Vyrix Pharmaceutical Inc. subsidiary of Ampio Pharmaceuticals Inc. (NYSE-M:AMPE) withdrew its proposed IPO on NYSE MKT, citing market conditions. In April, Vyrix filed to raise up to $28.8 million. Aegis Capital and…

    Published on 11/24/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993